Finanzwire Finanzwire
Basculer en Français
10055 Companies
205405 Keywords
135630 Articles
108893 Press releases
Headlines Articles Press releases BIOMERIEUX Remove
  1. Home
  2. Companies
  3. BIOMERIEUX
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • REGULATED PRESS RELEASE

    published on 01/08/2024 at 08:22, 2 years 2 months ago

    bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

    bioMérieux has acquired LUMED, a software company specializing in clinical decision support systems to optimize antimicrobial prescriptions and monitor healthcare-associated infections. This acquisition reinforces bioMérieux's commitment to combat antimicrobial resistance and improve infection prevention and control through advanced software solutions.
    BioMérieux LUMED Antimicrobial Resistance Clinical Decision Support System Infection Prevention And Control
    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/26/2023 at 07:01, 2 years 4 months ago

    bioMérieux – Third-Quarter 2023 Business Review

    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/19/2023 at 08:00, 2 years 5 months ago

    bioMérieux makes strategic investment in Oxford Nanopore

    Logo of BIOMERIEUX
  • REGULATED PRESS RELEASE

    published on 10/13/2023 at 07:02, 2 years 5 months ago

    bioMérieux announces CE-marking of VIDAS® TBI (GFAP, UCH-L1), a test for improved assessment of patients with mild traumatic brain injury, including concussion

    Logo of BIOMERIEUX
Previous page
1 ... 10 11
Accesswire
  • Published on 03/20/2026 at 00:20, 39 minutes ago

    Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A

  • Published on 03/20/2026 at 00:20, 39 minutes ago

    Reeflex Solutions Inc. Announces Revocation of Management Cease Trade Order

  • Published on 03/19/2026 at 21:16, 3 hours 43 minutes ago

    Unusual Machines, Inc. Announces Proposed Public Offering

  • Published on 03/19/2026 at 14:20, 10 hours 39 minutes ago

    CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report

  • Published on 03/19/2026 at 13:50, 11 hours 9 minutes ago

    Predictiv AI Appoints Multi-Agent Systems Pioneer Professor George Rzevski as Strategic Advisor to Advance Swarm AI Platforms

View all ACCESSWIRE
EQS Group
  • Published on 03/19/2026 at 23:48, 1 hour 11 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice

  • Published on 03/19/2026 at 22:55, 2 hours 4 minutes ago

    Baristas behind millions of cups of coffee compete globally

  • Published on 03/19/2026 at 22:48, 2 hours 11 minutes ago

    EQS-Adhoc: Forecast for the 2026 financial year

  • Published on 03/19/2026 at 19:30, 5 hours 29 minutes ago

    EEII AG: Publication of Listing Prospectus

  • Published on 03/19/2026 at 19:24, 5 hours 35 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS
Les Echos
  • Published on 03/19/2026 at 18:00, 6 hours 59 minutes ago

    Filing of the 2025 Universal Registration Document

  • Published on 03/19/2026 at 15:00, 9 hours 59 minutes ago

    Statement Accor

  • Published on 03/19/2026 at 08:45, 16 hours 14 minutes ago

    Deezer and Sonos renew and expand long-term collaboration

  • Published on 03/19/2026 at 07:00, 17 hours 59 minutes ago

    bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe

  • Published on 03/19/2026 at 07:00, 17 hours 59 minutes ago

    2025 Annual results and new strategic signature

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy